Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.368EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.404EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.306EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.328EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.533EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.120.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.528EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.91 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.617EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.383EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.95 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.189EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
C.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.545EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.482EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.564EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.461EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.486EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.603EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.606EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.601EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.186EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.324EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.525EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.480EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.214EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.304EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.214.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.577EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.639EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.270EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.227EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
U.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used